Bevacizumab/Cyclophosphamide Regimen

Preferred Label : Bevacizumab/Cyclophosphamide Regimen;

NCIt synonyms : Bevacizumab Cyclophosphamide; Bevacizumab-Cyclophosphamide Regimen; Bevacizumab-Cyclophosphamide; Bevacizumab/Cyclophosphamide; Cyclophosphamide/Bevacizumab; Bevacizumab/Oral Cyclophosphamide; Oral Cyclophosphamide Plus Bevacizumab;

NCIt definition : A regimen consisting of bevacizumab and cyclophosphamide that can be used for the treatment of cervical, ovarian, fallopian tube, and primary peritoneal cancers.;

Détails

Origin ID

C37555;

UMLS CUI

C1328090;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bevacizumab [NCIt concept]
- Cyclophosphamide [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients